{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:16:49Z","timestamp":1791170209316,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.lungcan.2013.02.017","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T01:33:29Z","timestamp":1363138409000},"page":"256-262","source":"Crossref","is-referenced-by-count":53,"title":["Tumor-associated macrophages in thoracic malignancies"],"prefix":"10.1016","volume":"80","author":[{"given":"L.A.","family":"Lievense","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bezemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.J.V.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.J.J.","family":"Hegmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.lungcan.2013.02.017_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10555-007-9072-0","article-title":"Inflammatory cell infiltration of tumors: Jekyll or Hyde","volume":"26","author":"Talmadge","year":"2007","journal-title":"Cancer Metastasis Rev"},{"issue":"6832","key":"10.1016\/j.lungcan.2013.02.017_bib0010","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"6024","key":"10.1016\/j.lungcan.2013.02.017_bib0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2013.02.017_bib0030","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.168.9.4272","article-title":"Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation","volume":"168","author":"Woo","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0035","first-page":"642","article-title":"Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism","volume":"63","author":"Batra","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4161\/cbt.4.3.1644","article-title":"Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma","volume":"4","author":"DeLong","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"10.1016\/j.lungcan.2013.02.017_bib0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.06.00135305","article-title":"Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses","volume":"27","author":"Hegmans","year":"2006","journal-title":"Eur Respir J"},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2013.02.017_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2005.11.005","article-title":"Foxp3 expressing CD4+CD25+ and CD8+CD28\u2212 T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma","volume":"67","author":"Meloni","year":"2006","journal-title":"Hum Immunol"},{"issue":"10","key":"10.1016\/j.lungcan.2013.02.017_bib0055","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2217\/imt.12.108","article-title":"Dendritic cell-based immunotherapy in mesothelioma","volume":"4","author":"Cornelissen","year":"2012","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.lungcan.2013.02.017_bib0060","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/S1470-2045(12)70126-2","article-title":"Immunotherapies for non-small-cell lung cancer and mesothelioma","volume":"13","author":"Thomas","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.lungcan.2013.02.017_bib0065","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1164\/rccm.200909-1465OC","article-title":"Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma","volume":"181","author":"Hegmans","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0070","first-page":"927240","article-title":"New roads open up for implementing immunotherapy in mesothelioma","author":"Cornelissen","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"10.1016\/j.lungcan.2013.02.017_bib0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00002371-200111000-00001","article-title":"Tumor-induced immune dysfunctions caused by myeloid suppressor cells","volume":"24","author":"Bronte","year":"2001","journal-title":"J Immunother"},{"issue":"5","key":"10.1016\/j.lungcan.2013.02.017_bib0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","article-title":"Cancer related inflammation: the macrophage connection","volume":"267","author":"Sica","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","article-title":"The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance","volume":"222","author":"Allavena","year":"2008","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcancer.2005.11.005","article-title":"Regulatory T cells in immune surveillance and treatment of cancer","volume":"16","author":"Yamaguchi","year":"2006","journal-title":"Semin Cancer Biol"},{"issue":"9255","key":"10.1016\/j.lungcan.2013.02.017_bib0100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"5C","key":"10.1016\/j.lungcan.2013.02.017_bib0115","first-page":"3335","article-title":"Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer","volume":"24","author":"Ohno","year":"2004","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000012021","article-title":"Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis","volume":"57","author":"Takanami","year":"1999","journal-title":"Oncology"},{"issue":"20","key":"10.1016\/j.lungcan.2013.02.017_bib0125","first-page":"4625","article-title":"Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma","volume":"56","author":"Leek","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0130","first-page":"445","article-title":"Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival","volume":"17","author":"Lissbrant","year":"2000","journal-title":"Int J Oncol"},{"issue":"7","key":"10.1016\/j.lungcan.2013.02.017_bib0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","article-title":"Prognostic value of tumor-associated macrophage count in human bladder cancer","volume":"7","author":"Hanada","year":"2000","journal-title":"Int J Urol"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/imt.11.178","article-title":"Myeloid suppressor cells and immune modulation in lung cancer","volume":"4","author":"Srivastava","year":"2012","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1479-5876-9-216","article-title":"Identification and manipulation of tumor associated macrophages in human cancers","volume":"9","author":"Heusinkveld","year":"2011","journal-title":"J Transl Med"},{"issue":"9","key":"10.1016\/j.lungcan.2013.02.017_bib0155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jnci\/djs235","article-title":"Macrophages: cancer therapy's double-edged sword","volume":"104","author":"Brower","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.lungcan.2013.02.017_bib0160","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front Biosci"},{"issue":"10","key":"10.1016\/j.lungcan.2013.02.017_bib0175","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yexcr.2012.09.006","article-title":"Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response","volume":"319","author":"Chen","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0185","first-page":"201026","article-title":"Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation","author":"Schmid","year":"2010","journal-title":"J Oncol"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0190","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","article-title":"The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","article-title":"Differential macrophage programming in the tumor microenvironment","volume":"33","author":"Ruffell","year":"2012","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9440(10)62038-X","article-title":"Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies","volume":"167","author":"Lewis","year":"2005","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.lungcan.2013.02.017_bib0205","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.imbio.2012.07.002","article-title":"Influence of low oxygen tensions on macrophage polarization","volume":"217","author":"Escribese","year":"2012","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr1679","article-title":"Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2","volume":"9","author":"Lewis","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0888-7543(03)00215-5","article-title":"Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis","volume":"83","author":"White","year":"2004","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0220","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/cancers4030618","article-title":"Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors","volume":"4","author":"Ran","year":"2012","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0225","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)64255-1","article-title":"Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis","volume":"161","author":"Schoppmann","year":"2002","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0230","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s12032-010-9638-5","article-title":"Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma","volume":"28","author":"Zhang","year":"2011","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/modpathol.2011.182","article-title":"Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma","volume":"25","author":"Storr","year":"2012","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0240","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.180.4.2011","article-title":"Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms","volume":"180","author":"Biswas","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.08-0978","article-title":"The new lung cancer staging system","volume":"136","author":"Detterbeck","year":"2009","journal-title":"Chest"},{"issue":"2653","key":"10.1016\/j.lungcan.2013.02.017_bib0255","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.102.2653.456","article-title":"Relationships of lymphocytes and cancer","volume":"102","author":"Kelsall","year":"1945","journal-title":"Science"},{"issue":"7994","key":"10.1016\/j.lungcan.2013.02.017_bib0260","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(76)91014-X","article-title":"Macrophages against cancer","volume":"2","author":"Kinchner","year":"1976","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.lungcan.2013.02.017_bib0265","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1200\/JCO.2005.01.4910","article-title":"Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer","volume":"23","author":"Welsh","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0270","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2407-10-220","article-title":"The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer","volume":"10","author":"Dai","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0275","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09031936.00065708","article-title":"Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival","volume":"33","author":"Ohri","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2407-10-112","article-title":"The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time","volume":"10","author":"Ma","year":"2010","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0285","doi-asserted-by":"crossref","first-page":"E227","DOI":"10.1002\/ijc.27403","article-title":"Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer","volume":"131","author":"Chung","year":"2012","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2013.02.017_bib0290","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/JTO.0b013e3181eba692","article-title":"Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma","volume":"5","author":"Ohtaki","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"11","key":"10.1016\/j.lungcan.2013.02.017_bib0295","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1590\/S1807-59322011001100006","article-title":"M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma","volume":"66","author":"Zhang","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.00129306","article-title":"Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer","volume":"30","author":"Zeni","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1756-9966-30-62","article-title":"Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer","volume":"30","author":"Wang","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.lungcan.2013.02.017_bib0310","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1023\/A:1008375208574","article-title":"Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer","volume":"11","author":"Hatanaka","year":"2000","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.lungcan.2011.04.009","article-title":"Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression","volume":"74","author":"Wang","year":"2011","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2013.02.017_bib0320","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/JTO.0b013e3181b27799","article-title":"The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer","volume":"4","author":"Vallieres","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"14","key":"10.1016\/j.lungcan.2013.02.017_bib0325","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9483","key":"10.1016\/j.lungcan.2013.02.017_bib0330","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.lungcan.2013.02.017_bib0335","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00262-011-1103-6","article-title":"Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma","volume":"60","author":"Bograd","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.02.034","article-title":"Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune response-based therapies","volume":"322","author":"Izzi","year":"2012","journal-title":"Cancer Lett"},{"issue":"26","key":"10.1016\/j.lungcan.2013.02.017_bib0345","first-page":"1007","article-title":"Lymphocytic infiltration of pleural mesothelioma and its significance for survival","volume":"61","author":"Leigh","year":"1982","journal-title":"S Afr Med J"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0350","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.V74.3.940.940","article-title":"Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro","volume":"74","author":"Demetri","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0355","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ijc.2910510220","article-title":"Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature","volume":"51","author":"Schmitter","year":"1992","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0360","first-page":"543","article-title":"Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages","volume":"34","author":"Izzi","year":"2009","journal-title":"Int J Oncol"},{"issue":"12","key":"10.1016\/j.lungcan.2013.02.017_bib0365","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/0008-5472.CAN-05-0141","article-title":"Tumor cyclooxygenase-2\/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer","volume":"65","author":"Sharma","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0370","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4049\/jimmunol.175.3.1483","article-title":"Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells","volume":"175","author":"Baratelli","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.lungcan.2013.02.017_bib0375","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjc.6605814","article-title":"Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma","volume":"103","author":"Veltman","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0380","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1158\/1535-7163.MCT-07-0579","article-title":"Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma","volume":"7","author":"Miselis","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"22","key":"10.1016\/j.lungcan.2013.02.017_bib0385","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1002\/cncr.26143","article-title":"Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma","volume":"117","author":"Burt","year":"2011","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2013.02.017_bib0390","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/carcin\/bgr128","article-title":"COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin\/+ mouse polyps","volume":"32","author":"Nakanishi","year":"2011","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1158\/0008-5472.CAN-09-2326","article-title":"CCL2 blockade augments cancer immunotherapy","volume":"70","author":"Fridlender","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0400","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.icb.7100116","article-title":"TGFbeta is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction","volume":"86","author":"Byrne","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"18","key":"10.1016\/j.lungcan.2013.02.017_bib0405","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0410","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","article-title":"Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy","volume":"1","author":"DeNardo","year":"2011","journal-title":"Cancer Discov"},{"issue":"8","key":"10.1016\/j.lungcan.2013.02.017_bib0415","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2011-09-379214","article-title":"Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling","volume":"119","author":"Hume","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.lungcan.2013.02.017_bib0420","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1172\/JCI27648","article-title":"Targeting tumor-associated macrophages as a novel strategy against breast cancer","volume":"116","author":"Luo","year":"2006","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0425","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-007-0389-x","article-title":"A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis","volume":"57","author":"Lewen","year":"2008","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10.1016\/j.lungcan.2013.02.017_bib0430","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.20080124","article-title":"An antiinflammatory role for IKKbeta through the inhibition of \u201cclassical\u201d macrophage activation","volume":"205","author":"Fong","year":"2008","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.lungcan.2013.02.017_bib0435","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","article-title":"Re-educating\u201d tumor-associated macrophages by targeting NF-kappaB","volume":"205","author":"Hagemann","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0440","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2567.2010.03357.x","article-title":"Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages","volume":"132","author":"Buhtoiarov","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0445","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1423-0127-17-32","article-title":"Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination","volume":"17","author":"Chuang","year":"2010","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0450","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1479-5876-9-177","article-title":"Tumour macrophages as potential targets of bisphosphonates","volume":"9","author":"Rogers","year":"2011","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0455","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00262-009-0776-6","article-title":"Type I interferons inhibit the generation of tumor-associated macrophages","volume":"59","author":"U\u2019Ren","year":"2010","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10.1016\/j.lungcan.2013.02.017_bib0460","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis","volume":"95","author":"von Marschall","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0465","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2011.01.005","article-title":"Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity","volume":"19","author":"Huang","year":"2011","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.lungcan.2013.02.017_bib0475","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.lungcan.2013.02.017_bib0480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0485","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","article-title":"HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF","volume":"19","author":"Rolny","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0490","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12016-007-8058-6","article-title":"Histidine-rich glycoprotein modulation of immune\/autoimmune, vascular, and coagulation systems","volume":"34","author":"Blank","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.lungcan.2013.02.017_bib0495","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780802567250","article-title":"Tirapazamine: a novel agent targeting hypoxic tumor cells","volume":"18","author":"Reddy","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.lungcan.2013.02.017_bib0500","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.lungcan.2007.03.023","article-title":"HIF1a expression in bronchial biopsies correlates with tumor microvascular saturation determined using optical spectroscopy","volume":"57","author":"Aerts","year":"2007","journal-title":"Lung Cancer"},{"issue":"22","key":"10.1016\/j.lungcan.2013.02.017_bib0505","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1158\/1078-0432.CCR-06-1124","article-title":"Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma","volume":"12","author":"Yasuda","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.lungcan.2013.02.017_bib0510","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1200\/JCO.2005.04.0436","article-title":"Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB\/IV non-small-cell lung cancer","volume":"24","author":"Yasuda","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0515","first-page":"158","article-title":"Exercise, physical activity and breast cancer: the role of tumor-associated macrophages","volume":"18","author":"Goh","year":"2012","journal-title":"Exerc Immunol Rev"},{"key":"10.1016\/j.lungcan.2013.02.017_bib0520","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/1471-2407-12-580","article-title":"Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment","volume":"12","author":"Heuvers","year":"2012","journal-title":"BMC Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T20:21:59Z","timestamp":1595535719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0169500213000767"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.02.017","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}